FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| QuVa Pharma | 079937015 | 70092-086 | 70092-086-44 | Succinylcholine Chloride | 100 mg/5 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-269 | 70092-269-37 | Bupivacaine Hydrochloride Anhydrous; Fentanyl Citrate | 156.25 mg/250 mL; 500 ug/250 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-148 | 70092-148-43 | Trisodium Citrate Dihydrate | 120 mg/3 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-054 | 70092-054-05 | Vancomycin Hydrochloride | 1.25 g/250 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-056 | 70092-056-05 | Vancomycin Hydrochloride | 1.5 g/250 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-648 | 70092-648-36 | Vasopressin | .2 U/100 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-604 | 70092-604-47 | Cefazolin Sodium | 2 g/100 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-621 | 70092-621-15 | Cefazolin Sodium | 2 g/100 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-603 | 70092-603-46 | Cefazolin Sodium | 1 g/100 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-623 | 70092-623-03 | Cefazolin Sodium | 3 g/100 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-622 | 70092-622-03 | Cefazolin Sodium | 2 g/100 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-600 | 70092-600-44 | Dexmedetomidine Hydrochloride | 20 ug/5 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-575 | 70092-575-36 | Diltiazem Hydrochloride | 125 mg/125 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-478 | 70092-478-44 | Ephedrine Sulfate | 25 mg/5 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-455 | 70092-455-46 | Ephedrine Sulfate | 50 mg/10 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-477 | 70092-477-44 | Ephedrine Sulfate | 50 mg/5 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-094 | 70092-094-36 | Fentanyl Citrate | 2 mg/100 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-415 | 70092-415-47 | Fentanyl Citrate | 1000 ug/20 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-400 | 70092-400-43 | Fentanyl Citrate | 10 ug/1 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-250 | 70092-250-75 | Fentanyl Citrate | 1 mg/100 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-097 | 70092-097-43 | Fentanyl Citrate | 100 ug/2 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-180 | 70092-180-79 | Fentanyl Citrate | 1500 ug/30 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-092 | 70092-092-36 | Fentanyl Citrate | 1 mg/100 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-093 | 70092-093-37 | Fentanyl Citrate | 2500 ug/250 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-098 | 70092-098-44 | Fentanyl Citrate | 250 ug/5 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-100 | 70092-100-50 | Fentanyl Citrate | 2750 ug/55 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-509 | 70092-509-35 | Fentanyl Citrate | 2.5 mg/50 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-444 | 70092-444-05 | Fentanyl Citrate | 1250 ug/250 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-099 | 70092-099-49 | Fentanyl Citrate | 1500 ug/30 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-105 | 70092-105-37 | Fentanyl Citrate; Bupivacaine Hydrochloride | 500 ug/250 mL; 31.25 mg/250 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-104 | 70092-104-36 | Fentanyl Citrate; Bupivacaine Hydrochloride | 200 ug/100 mL; 125 mg/100 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-435 | 70092-435-46 | Acetaminophen | 100 mg/10 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-255 | 70092-255-75 | Fentanyl Citrate; Bupivacaine Hydrochloride | 200 ug/100 mL; 100 mg/100 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-202 | 70092-202-75 | Fentanyl Citrate; Bupivacaine Hydrochloride | 200 ug/100 mL; 125 mg/100 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-500 | 70092-500-37 | Fentanyl Citrate; Bupivacaine Hydrochloride | 500 ug/250 mL; 250 mg/250 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-160 | 70092-160-37 | Fentanyl Citrate; Bupivacaine Hydrochloride | 500 ug/250 mL; 250 mg/250 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-103 | 70092-103-36 | Fentanyl Citrate; Bupivacaine Hydrochloride Anhydrous | 200 ug/100 mL; 100 mg/100 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-441 | 70092-441-76 | Fentanyl Citrate; Ropivacaine Hydrochloride | 400 ug/200 mL; 200 mg/200 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-108 | 70092-108-36 | Fentanyl Citrate; Ropivacaine Hydrochloride | 200 ug/100 mL; 200 mg/100 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-225 | 70092-225-37 | Fentanyl Citrate; Ropivacaine Hydrochloride | 500 ug/250 mL; 500 mg/250 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-504 | 70092-504-36 | Fentanyl Citrate; Ropivacaine Hydrochloride | 200 ug/100 mL; 200 mg/100 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-399 | 70092-399-75 | Fentanyl Citrate; Ropivacaine Hydrochloride | 200 ug/100 mL; 100 mg/100 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-593 | 70092-593-50 | Adenosine; Lidocaine Hydrochloride Anhydrous | 39.9 mg/40 mL; 40 mg/40 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-083 | 70092-083-44 | Glycopyrrolate | 1 mg/5 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-281 | 70092-281-08 | Heparin Sodium | 9000 ug/1000 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-117 | 70092-117-79 | Hydromorphone Hydrochloride | 30 mg/30 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-118 | 70092-118-50 | Hydromorphone Hydrochloride | 50 mg/50 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-290 | 70092-290-49 | Hydromorphone Hydrochloride | 15 mg/30 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-113 | 70092-113-79 | Hydromorphone Hydrochloride | 6 mg/30 mL | 2022-1 | valid | 2026-11-12 | |
| QuVa Pharma | 079937015 | 70092-546 | 70092-546-35 | Hydromorphone Hydrochloride | 50 mg/50 mL | 2022-1 | valid | 2026-11-12 |